U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 30, 2002
COMMISSION FILE NUMBER: 000-32141
Nutra Pharma Corp.
(Exact name of registrant as specified in its charter)
California 91-2021600
- ----------------------------------------- -------------------------
(State or jurisdiction of incorporation (I.R.S. Employer I.D. No.)
or organization
485 Martin Lane, Beverly Hills, California 90210
(Address of principal executive offices) (Zip Code)
- ------------------------------------------ ----------------
Registrant's telephone number: (310) 858-7088
4900 9th Avenue NW, Suite 201, Seattle, Washington 98102
---------------------------------------------------------
(Former name or former address, if changed since last report)
Item 1. Change In Control of Registrant
Not Applicable
Item 2. Acquisition or Disposition of Assets
Not Applicable
Item 3. Bankruptcy or Receivership
Not Applicable
Item 4. Changes in Registrant's Certifying Accountant
Not Applicable
Item 5. Other Events
Not Applicable
Item 6. Resignations of Registrant's Directors
Effective October 26, 2002, Officer and Director Dr. Edith W. Martin has
resigned from the Company's Board of Directors. On September 15, 2002, Dr.
Harold Crews resigned from the Company's Board of Directors.
Item 7. Financial Statements and Exhibits
None
c. Exhibits.
None
This amendment is filed to correct typographical errors made by the EDGAR
filer contained in the original current report on Form 8K filed October 30,
2002.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: October 31, 2002
Nutra Pharma Corp.
Zirk Englebrecht
By: Zirk Engelbrecht, Chairman,
Board of Directors/VP
In connection with the current report of Nutra Pharma Corp. (the "Company") on
Form 8K for September 15, 2002, as filed with the Securities and Exchange
Commission on the date hereof, Zirk Englebrecht and Nancy Volpe certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of their knowledge:
1. The report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the report fairly presents, in all
material respects, the financial condition and results of the Company.
Dated: October 31, 2002 By: Zirk Englebrecht
------------------------------
Chairman, Board of Directors/VP
Dated: October 31, 2002 By: Nancy Volpe
-----------------------------
Nancy Volpe, Secretary/Treasurer